Dentsply Sirona Appoints New CFO Matthew E. Garth

The latest announcement is out from DENTSPLY SIRONA ( (XRAY) ).

On May 27, 2025, Dentsply Sirona announced the appointment of Matthew E. Garth as Executive Vice President and Chief Financial Officer, effective May 30, 2025. Mr. Garth brings nearly 30 years of financial management experience, having previously served in senior roles at The Scotts Miracle-Gro Company and Minerals Technologies Inc. His appointment is seen as a strategic move to drive Dentsply Sirona’s transformational journey and enhance shareholder value, with a focus on advancing the company’s financial, operational, and strategic goals.

The most recent analyst rating on (XRAY) stock is a Hold with a $30.00 price target. To see the full list of analyst forecasts on DENTSPLY SIRONA stock, see the XRAY Stock Forecast page.

Spark’s Take on XRAY Stock

According to Spark, TipRanks’ AI Analyst, XRAY is a Neutral.

DENTSPLY SIRONA faces significant financial difficulties, with negative profitability impacting valuation. Despite technical indicators showing near-term momentum, broader operational and market challenges persist. Recent corporate changes add uncertainty, but the company’s focus on innovation and operational efficiency offers some positive outlook.

To see Spark’s full report on XRAY stock, click here.

More about DENTSPLY SIRONA

Dentsply Sirona is the world’s largest diversified manufacturer of professional dental products and technologies, with a history of innovation and service to the dental industry and patients worldwide. The company develops, manufactures, and markets a comprehensive range of dental and oral health products, as well as other consumable medical devices under a strong portfolio of world-class brands. Dentsply Sirona is headquartered in Charlotte, North Carolina, and its shares are listed on Nasdaq under the symbol XRAY.

Average Trading Volume: 3,267,058

Technical Sentiment Signal: Sell

Current Market Cap: $3.26B

Find detailed analytics on XRAY stock on TipRanks’ Stock Analysis page.